Cell death pathways as therapeutic targets in rhabdomyosarcoma

HIGHLIGHTS

• who: Sarcoma and collaborators from the Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstraße, a, Frankfurt, Germany have published the research work: Cell Death Pathways as Therapeutic Targets in Rhabdomyosarcoma, in the Journal: (JOURNAL) of 14/Oct/2011
• what: Programmed cell death is a key regulator of tissue homeostasis and plays a central role in tumorigenesis.
• future: These findings point to a potential impact of strategies that antagonize IAP proteins in RMS and suggest that additional studies are required to evaluate IAP proteins as therapeutic targets in RMS.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.